AAPG Ascentage Pharma: Company Short-Term Debts

Symbol and logo of brand Ascentage Pharma Group (AAPG)

Ascentage Pharma Group develops oncology drugs in the US and China, focusing on the therapy of resistant forms of cancer. Short-term borrowings with maturities of up to one year demonstrate the dynamics of liabilities, while 0.12 represents the latest level value. The diversity of apoptosome inhibitor programs minimizes patent threats. The company is currently scaling global sales through partnerships with pharmaceutical behemoths.

AAPG Ascentage Pharma Group International Company Short-Term Loans and Borrowings (01/25/2025 - 10/30/2026)

AAPG (Ascentage Pharma Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Ascentage Pharma|AAPG - Consensus Target
- company stock capitalization data:
Market Capitalization Ascentage Pharma Group|AAPG - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Ascentage Pharma|AAPG - Accounting Value of Company|Market Cap to Net Assets Ratio ascentage.com|AAPG - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Ascentage Pharma Group|AAPG - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Ascentage Pharma Group|AAPG - Company Aggregate Debts|Debt to Book Capitalization Ratio Ascentage Pharma Group|AAPG - Company Long-Term Loans and Borrowings|Company Short-Term Debts Ascentage Pharma|Quick Ratio ascentage.com
- earnings and multiples data:
AAPG - Net Profit
Analysis of all company metrics:AAPG - Ascentage Pharma
Manufactured products of ascentage.com

For Ascentage Pharma Group (AAPG), liabilities maturing within one year reflect a balance between aggressive funding of oncology R&D and liquidity. The trend in total short-term liabilities demonstrates the speed of capital raising, which is critical given the revenue dependence on government reimbursement in China: a sharp increase in this indicator signals refinancing risks, while a decrease indicates a conservative approach to expansion.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt CG Oncology Therapeutics (CGON)|Company Short-Term Debt UroGen Pharma Ltd.|BCAX: Company Short-Term Loans and Borrowings|Company Current Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts DCTH (Delcath)|YMAB - Company Current Liabilities|AURA: Company Current Liabilities|CADL - Company Short-Term Debts|Accuray (ARAY) - Company Short-Term Debt|SELLAS Life Sciences Group - Company Short-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Short-Term Debts HURA|Company Short-Term Debts protaratx.com (TARA)|Company Short-Term Debt Fate Therapeutics FATE|Short-Term Debt Volume Aadi Bioscience, Inc. (WHWK)|TScan - Company Short-Term Debts|Champions Oncology (CSBR) - Company Current Liabilities|XBIT: Company Short-Term Debts|Short-Term Debt CEL-SCI (CVM)|Company Short-Term Debt OS Therapies|Company Short-Term Indebtedness RADX (Radiopharm Theranostics Ltd)|Company Current Liabilities ARTV (Artiva Biotherapeutics, Inc.)|Amount of Current Liabilities ANL|Company Short-Term Debts VERU (Veru Inc.)|Company Short-Term Debts tempesttx.com TPST|Xilio - Company Short-Term Debts|Short-Term Indebtedness Renovaro Inc. (RENB)|MURA: Company Short-Term Debts|Short-Term Debt Kairos Pharma (KAPA)|Company Current Liabilities OKUR|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debt Curis, Inc. (CRIS)|APLM: Current Liabilities|Company Short-Term Debts THAR (Tharimmune Corp)|Company Short-Term Loans and Borrowings ADVB|Genprex, Inc. - Company Short-Term Debts|CLDI - Company Short-Term Debts|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Xenetic Biosciences, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Salarius|Company Current Liabilities Kitov Pharma (PPBT)|Company Short-Term Debts AONC|Company Short-Term Debts beigene.com (BGNE)|Checkpoint Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings ELEV|iCAD Corp - Company Short-Term Debts|Short-Term Indebtedness Ikena Oncology, Inc. (IKNA)|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Viracta Therapeutics, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt MorphoSys|Short-Term Debt NAYA Biosciences Inc NAYA|Company Current Liabilities AAPGV (Ascentage Pharma Group Ltd)